Cargando…

The clinical significance of c-Kit mutations in metastatic oral mucosal melanoma in China

c-Kit mutations are frequently detected in mucosal melanomas, but their clinical significance in metastatic oral mucosal melanomas (OMM) remains unclear. The main purpose of this study was to investigate the clinical and pathological features of metastatic OMMs with c-Kit mutations and the efficienc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ma, Xuhui, Wu, Yunteng, Zhang, Tian, Song, Hao, Jv, Houyu, Guo, Wei, Ren, Guoxin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5669918/ https://www.ncbi.nlm.nih.gov/pubmed/29137292 http://dx.doi.org/10.18632/oncotarget.19746

Ejemplares similares

Ki67 Proliferation Index as a Histopathological Predictive and Prognostic Parameter of Oral Mucosal Melanoma in Patients without Distant Metastases
por: Ma, Xuhui, et al.
Publicado: (2017)

Loss of nuclear BAP1 expression is associated with poor prognosis in oral mucosal melanoma
por: Song, Hao, et al.
Publicado: (2017)

Cisplatin based induction chemotherapy modified by ERCC1 improved the outcome of young adults with locally advanced oral squamous cell carcinoma
por: Gong, Yin, et al.
Publicado: (2019)

Analysis of c-KIT expression and KIT gene mutation in human mucosal melanomas
por: Satzger, I, et al.
Publicado: (2008)

A pilot study of camrelizumab with docetaxel and cisplatin for the first line treatment in recurrent/metastatic oral squamous cell carcinoma
por: Ju, Houyu, et al.
Publicado: (2023)

Candidate therapeutic agents in a newly established triple wild‐type mucosal melanoma cell line
por: Shi, Chaoji, et al.
Publicado: (2022)

Extranodal marginal zone B‐cell lymphoma of mucosa‐associated lymphoid tissue in the oromaxillofacial head and neck region: A retrospective analysis of 105 patients
por: Zhang, Tian, et al.
Publicado: (2019)

KIT, NRAS, BRAF and FMNL2 mutations in oral mucosal melanoma and a systematic review of the literature
por: Chen, Feng, et al.
Publicado: (2018)

KIT, NRAS and BRAF mutations in sinonasal mucosal melanoma: a study of 56 cases
por: Zebary, A, et al.
Publicado: (2013)

GNAQ mutation in a patient with metastatic mucosal melanoma
por: Kim, Chung-Young, et al.
Publicado: (2014)

KIT Somatic Mutations and Immunohistochemical Expression in Canine Oral Melanoma
por: Brocca, Ginevra, et al.
Publicado: (2020)

Clinical significance of BRAF mutations in metastatic melanoma
por: Chang, David Z, et al.
Publicado: (2004)

Treatment of Primary and Metastatic Multifocal Mucosal Melanoma of the Oral Cavity with Imatinib
por: Deinlein, Teresa, et al.
Publicado: (2017)

Metabolic response by FDG-PET to imatinib correlates with exon 11 KIT mutation and predicts outcome in patients with mucosal melanoma
por: Zukotynski, Katherine, et al.
Publicado: (2014)

Prognostic Roles of BRAF, KIT, NRAS, IGF2R and SF3B1 Mutations in Mucosal Melanomas
por: Wróblewska, Joanna P., et al.
Publicado: (2021)

Reactive cutaneous capillary endothelial proliferation predicted the efficacy of camrelizumab in patients with recurrent/metastatic head and neck squamous cell carcinoma
por: Ding, Qi, et al.
Publicado: (2023)

Efficacy and safety of ripretinib in patients with KIT-altered metastatic melanoma
por: Janku, F., et al.
Publicado: (2022)

Oral mucosal melanoma: Case report
por: Lin, Chieh-Wei, et al.
Publicado: (2020)

Amelanotic Acral Melanoma Associated with KIT Mutation and Vitiligo
por: Kim, Young Jee, et al.
Publicado: (2015)

KIT Mutation Incidence and Pattern of Melanoma in Central Europe
por: Doma, V., et al.
Publicado: (2019)

The Prognostic Significance of Low-Frequency Somatic Mutations in Metastatic Cutaneous Melanoma
por: Zhao, Xiaobei, et al.
Publicado: (2019)

Metastatic mucosal melanoma: imaging patterns of metastasis and recurrence
por: O’Regan, Kevin, et al.
Publicado: (2013)

Efficacy of Immunotherapy in Patients with Metastatic Mucosal or Uveal Melanoma
por: Mignard, Claire, et al.
Publicado: (2018)

Successful treatment with avapritinib in patient with mucosal metastatic melanoma
por: Cocorocchio, Emilia, et al.
Publicado: (2020)

Ultrasound hyperthermia induces apoptosis in head and neck squamous cell carcinoma: An in vitro study
por: Ren, Guoxin, et al.
Publicado: (2017)

A human mucosal melanoma organoid platform for modeling tumor heterogeneity and exploring immunotherapy combination options
por: Sun, Lulu, et al.
Publicado: (2023)

Targeted therapy in melanoma – the role of BRAF, RAS and KIT mutations
por: Goldinger, Simone M., et al.
Publicado: (2013)

Oral mucosal melanoma: a malignant trap
por: Symvoulakis, Emmanouil K, et al.
Publicado: (2006)

Whole-exome sequencing identifies recurrent SF3B1 R625 mutation and comutation of NF1 and KIT in mucosal melanoma
por: Hintzsche, Jennifer D., et al.
Publicado: (2017)

Atypical BRAF and NRAS Mutations in Mucosal Melanoma
por: Dumaz, Nicolas, et al.
Publicado: (2019)

Comparison of c-Kit expression between primary and metastatic melanoma of skin and mucosa
por: Sari Aslani, Fatemeh, et al.
Publicado: (2015)

Response to Imatinib in a Patient with Double-mutant KIT Metastatic Penile Melanoma
por: BEAUDOUX, Olivia, et al.
Publicado: (2021)

Mucosal Melanoma: Pathological Evolution, Pathway Dependency and Targeted Therapy
por: Ma, Yanni, et al.
Publicado: (2021)

Treatment Modalities of Recurrent Oral Mucosal Melanoma In Situ
por: Becker, Philipp, et al.
Publicado: (2021)

Telomere Maintenance Associated Mutations in the Genetic Landscape of Gynecological Mucosal Melanoma
por: Yuan, Guangwen, et al.
Publicado: (2020)

Metastatic Gastric Mucosal Melanoma: A Rare Case Presenting With Diffuse Gastric Polyposis
por: Yan, Zhi Hao, et al.
Publicado: (2023)

Survival after checkpoint inhibitors for metastatic acral, mucosal and uveal melanoma
por: Klemen, Nicholas D., et al.
Publicado: (2020)

Metabolic heterogeneity protects metastatic mucosal melanomas cells from ferroptosis
por: Lin, Weifan, et al.
Publicado: (2022)

Prognostic significance of LKB1 promoter methylation in cutaneous malignant melanoma
por: Zhang, Weiming, et al.
Publicado: (2017)

The association between body mass index and efficacy of pembrolizumab as second‐line therapy in patients with recurrent/metastatic head and neck squamous cell carcinoma
por: Zhang, Xinyi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_0ktifdn5bdvave4m73kakos86j